S&P TSX Capped Composite...

US Dollar vs CAD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

GRTS Gritstone bio Inc

0.8801

0.0801 (10.01%)

May 01 2024 - Closed

Delayed by 15 minutes

Gritstone Oncology trades high on key promotions

To read the full story on Seeking Alpha, click here.

Gritstone bio (NASDAQ:GRTS)
Historical Stock Chart
From Apr 2024 to May 2024

Click Here for more Gritstone bio Charts.

Gritstone bio (NASDAQ:GRTS)
Historical Stock Chart
From May 2023 to May 2024

Click Here for more Gritstone bio Charts.

Gritstone Oncology Inc News

Gritstone bio Highlights the Durability and Potential Broad Utility of its Self-amplifying mRNA (samRNA) COVID-19 Vaccine at ESCMID Global 2024
Tuesday 30 April 2024 (2 days ago) • GlobeNewswire Inc.

Gritstone bio Announces Appointment of Stephen Webster to its Board of Directors
Monday 29 April 2024 (3 days ago) • GlobeNewswire Inc.

Nature Medicine Publishes Interim Results from Gritstone bio’s Phase 1/2 Study of “Off-the-Shelf” Neoantigen Vaccine Platform (SLATE)
Monday 15 April 2024 (2 weeks ago) • GlobeNewswire Inc.

Gritstone bio to Participate in Upcoming Investor and Scientific Conferences
Monday 8 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Gritstone bio Presents Improvements to EDGE™ Platform at AACR 2024
Monday 8 April 2024 (3 weeks ago) • GlobeNewswire Inc.

Gritstone bio Announces Pricing of $32.5 Million Underwritten Public Offering
Monday 1 April 2024 (1 month ago) • GlobeNewswire Inc.

Gritstone bio Announces Proposed Public Offering
Monday 1 April 2024 (1 month ago) • GlobeNewswire Inc.

Gritstone bio Announces Positive Preliminary Progression-free Survival and Long-term Circulating Tumor DNA (ctDNA) Data from Phase 2 Portion of Ongoing Phase 2/3 Study of its Personalized Cancer Vaccine, GRANITE, in Front-line Metastatic Microsatellite Sta
Monday 1 April 2024 (1 month ago) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 5 March 2024 (2 months ago) • Edgar (US Regulatory)

Gritstone bio Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Updates
Tuesday 5 March 2024 (2 months ago) • GlobeNewswire Inc.

Gritstone bio Announces Workforce Reduction
Thursday 29 February 2024 (2 months ago) • GlobeNewswire Inc.

More Gritstone Oncology Inc News Articles

Global Developments (PK)

FBEC Worldwide (PK)

Mullen Automotive

NaturalShrimp (QB)

Atacama Resources (PK)

NioCorp Developments

Branded Legacy (PK)

Fannie Mae (QB)

MicroCloud Hologram

Tonner One World (PK)

International Star (PK)

Moon Equity (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions